Will RFK Break Pharma?

Robert F. Kennedy Jr. has announced plans for a presidential mandate to restore federal agencies, including the FDA, to the "gold standard" of scientific review. This bold proposal has significant implications for the life sciences industry, affecting drug advertisers, clinical researchers, and M&A attorneys. Key Takeaways by Sector For Drug AdvertisersExpect stricter scrutiny on advertising claims, requiring robust, data-driven evidence.Collaborations between marketing, regulatory, an...